OGEN
OGEN
AMEX · Biotechnology

Oragenics Inc

$0.56
+0.06 (+11.27%)
As of Mar 31, 5:05 PM ET ·
Financial Highlights (FY 2025)
Revenue
484.7K
Net Income
-93,000
Gross Margin
51.8%
Profit Margin
-19.2%
Rev Growth
+6.2%
D/E Ratio
0.77
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 51.8% 51.8% 51.8%
Operating Margin -17.0% -18.9% -21.4%
Profit Margin -19.2% -24.5% -21.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 484.7K 468.9K 455.7K
Gross Profit 250.9K 242.7K 235.9K
Operating Income -82,553 -88,778 -97,734
Net Income -93,000 -114,838 -98,507
Gross Margin 51.8% 51.8% 51.8%
Operating Margin -17.0% -18.9% -21.4%
Profit Margin -19.2% -24.5% -21.6%
Rev Growth +6.2% -0.5% +16.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.49M 1.53M 1.31M
Total Equity 1.95M 1.80M 1.90M
D/E Ratio 0.77 0.85 0.69
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -101,936 -104,145 -94,610
Free Cash Flow -84,967 -104,034 -103,597